Pharmaceuticals by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 pharmaceuticals ranked by one-year price change, at +403%, ahead of Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%). Figures as of 18 Nov 2026, 15:16 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+403%
- Median
- +26.9%
- Combined market value
- DKK 34.82T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +403% | DKK 32.5B | DKK 92.49 | 2.23% down | 403% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +286% | DKK 62.2B | DKK 654.43 | 2.43% up | 286% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +241% | DKK 45.2B | DKK 665.77 | 1.49% up | 241% up | ||
| 4 | VeradermicsMANE · Health Care | +233% | DKK 36.3B | DKK 859.23 | 0.41% up | 233% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +169% | DKK 27.4B | DKK 200.37 | 0.14% up | 169% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | DKK 51.6B | DKK 657.25 | 1.47% up | 126% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +113% | DKK 33.5B | DKK 595.48 | 0.52% up | 113% up | ||
| 8 | TG TherapeuticsTGTX · Health Care | +107% | DKK 65.4B | DKK 432.47 | 1.26% up | 107% up | ||
| 9 | ViatrisVTRS · Health Care | +95.5% | DKK 160.9B | DKK 140.33 | 0.76% up | 96% up | ||
| 10 | Roivant SciencesROIV · Health Care | +90.3% | DKK 192.3B | DKK 265.34 | 0.65% up | 90% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | DKK 31.1B | DKK 284.34 | 0.69% down | 88% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | DKK 51B | DKK 146.43 | 1.80% up | 83% up | ||
| 13 | Royalty PharmaRPRX · Health Care | +77.7% | DKK 269.1B | DKK 467.95 | 0.04% up | 78% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | DKK 338.1B | DKK 289.72 | 0.19% down | 74% up | ||
| 15 | GenmabGMAB · Health Care | +70.0% | DKK 217.5B | DKK 352.79 | 0.31% down | 70% up | ||
| 16 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | DKK 58.7B | DKK 2,099.76 | 1.07% up | 61% up | ||
| 17 | AlkermesALKS · Health Care | +58.4% | DKK 52.6B | DKK 313.25 | 1.20% up | 58% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +53.6% | DKK 466.7B | DKK 146.09 | 0.88% down | 54% up | ||
| 19 | Merck & CoMRK · Health Care | +50.8% | DKK 2.36T | DKK 958.01 | 1.89% down | 51% up | ||
| 20 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | DKK 56.3B | DKK 863.31 | 1.68% up | 46% up | ||
| 21 | Travere TherapeuticsTVTX · Health Care | +44.2% | DKK 33B | DKK 343.79 | 1.21% down | 44% up | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | DKK 40.5B | DKK 2,022.36 | 1.07% up | 43% up | ||
| 23 | Johnson & JohnsonJNJ · Health Care | +37.6% | DKK 4.53T | DKK 1,880.94 | 0.90% down | 38% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | DKK 106.3B | DKK 1,655.64 | 0.99% up | 37% up | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | DKK 677.2B | DKK 6,546.50 | 0.36% up | 36% up | ||
| 26 | Eli LillyLLY · Health Care | +34.9% | DKK 8.5T | DKK 9,538.38 | 1.06% down | 35% up | ||
| 27 | Bristol-Myers SquibbBMY · Health Care | +34.0% | DKK 838.4B | DKK 410.17 | 1.83% down | 34% up | ||
| 28 | Belite BioBLTE · Health Care | +31.0% | DKK 43.9B | DKK 1,080.26 | 0.57% up | 31% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | DKK 40.7B | DKK 624.12 | 0.34% down | 31% up | ||
| 30 | Ascendis PharmaASND · Health Care | +27.8% | DKK 120.6B | DKK 1,838.85 | 0.44% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | DKK 929.1B | DKK 3,664.55 | 0.72% up | 27% up | ||
| 32 | AbbVieABBV · Health Care | +25.7% | DKK 3.48T | DKK 1,970.09 | 1.21% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +25.0% | DKK 2.02T | DKK 1,068.27 | 1.43% down | 25% up | ||
| 34 | United TherapeuticsUTHR · Health Care | +22.6% | DKK 167.6B | DKK 3,936.02 | 1.06% down | 23% up | ||
| 35 | Elanco Animal HealthELAN · Health Care | +20.5% | DKK 89.5B | DKK 179.12 | 1.74% up | 20% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +17.2% | DKK 102.8B | DKK 527.89 | 0.92% up | 17% up | ||
| 37 | BeOne MedicinesONC · Health Care | +16.8% | DKK 315.1B | DKK 2,758.34 | 2.00% down | 17% up | ||
| 38 | PfizerPFE · Health Care | +14.4% | DKK 1.1T | DKK 192.56 | 0.69% down | 14% up | ||
| 39 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | DKK 55.5B | DKK 800.38 | 0.78% up | 13% up | ||
| 40 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | DKK 78.8B | DKK 406.59 | 2.03% up | 11% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | DKK 42B | DKK 297.09 | 1.47% up | 10% up | ||
| 42 | GSKGSK · Health Care | +6.26% | DKK 670B | DKK 334.26 | 0.32% down | 6% up | ||
| 43 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | DKK 85.1B | DKK 102.12 | 1.39% up | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +2.41% | DKK 1.9T | DKK 1,223.52 | 1.44% down | 2% up | ||
| 45 | GrifolsGRFS · Health Care | +1.41% | DKK 39.7B | DKK 58.40 | 0.64% down | 1% up | ||
| 46 | SanofiSNY · Health Care | -4.08% | DKK 775.7B | DKK 323.06 | 0.20% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -7.37% | DKK 48.2B | DKK 915.51 | 1.12% down | 7% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -7.92% | DKK 51.8B | DKK 473.47 | 0.78% down | 8% down | ||
| 49 | Novo NordiskNVO · Health Care | -16.9% | DKK 1.2T | DKK 272.66 | 1.63% down | 17% down | ||
| 50 | Abbott LaboratoriesABT · Health Care | -17.0% | DKK 1.23T | DKK 712.66 | 0.07% down | 17% down | ||
| 51 | PTC TherapeuticsPTCT · Health Care | -20.2% | DKK 34.5B | DKK 412.72 | 0.40% up | 20% down | ||
| 52 | CytokineticsCYTK · Health Care | -20.3% | DKK 49.4B | DKK 354.83 | 0.87% up | 20% down | ||
| 53 | Cogent BiosciencesCOGT · Health Care | -20.3% | DKK 33.9B | DKK 194.88 | 2.75% up | 20% down | ||
| 54 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | DKK 66.1B | DKK 2,847.22 | 0.93% down | 24% down | ||
| 55 | ABIVAXABVX · Health Care | -27.3% | DKK 50B | DKK 571.41 | 2.19% up | 27% down | ||
| 56 | ZoetisZTS · Health Care | -28.7% | DKK 230.8B | DKK 568.14 | 0.07% down | 29% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -35.6% | DKK 60.5B | DKK 75.60 | 4.03% up | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.1% | DKK 181B | DKK 824.89 | 0.61% down | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -42.5% | DKK 21.6B | DKK 111.22 | 1.37% up | 42% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | DKK 30.7B | DKK 184.06 | 0.24% up | 64% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | DKK 141.1B | DKK 1,053.46 | 1.16% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8106 DKK).
Questions and answers
Which pharmaceuticals rank first by one-year price change?
Erasca (+403%), Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%) are the top three of the 61 pharmaceuticals ranked by one-year price change as of 18 Nov 2026, 15:16 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by one-year price change have a combined market value of DKK 34.82T as of 18 Nov 2026, 15:16 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceuticals by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.